Loading…
Pelthos Therapeutics Inc. is projected to rise to $28.46 by 2027, a +6% move from its current price of $26.96. PTHS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $26.12 | $26.96 | $27.83 | 0.00% |
| May 30 | $25.78 | $26.96 | $28.20 | 0.00% |
| May 31 | $25.52 | $26.96 | $28.48 | 0.00% |
| Jun 1 | $25.31 | $26.96 | $28.72 | 0.00% |
| Jun 2 | $25.12 | $26.96 | $28.94 | +0.01% |
| Jun 3 | $24.95 | $26.96 | $29.14 | +0.01% |
| Jun 4 | $24.80 | $26.96 | $29.32 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.80 | $26.96 | $29.32 | +0.01% |
| Week 2 | $23.95 | $26.96 | $30.36 | +0.02% |
| Week 3 | $23.32 | $26.97 | $31.18 | +0.02% |
| Week 4 | $22.81 | $26.97 | $31.89 | +0.03% |
| Week 5 | $22.36 | $26.97 | $32.53 | +0.04% |
| Week 6 | $21.97 | $26.97 | $33.12 | +0.05% |
| Week 7 | $21.61 | $26.97 | $33.67 | +0.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pelthos Therapeutics Inc. is a bio-pharmaceutical company focused on developing and commercializing therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older.
It also provides NITRICIL, a proprietary nitric oxide-based technology platform.
Pelthos Therapeutics Inc. (PTHS) is a healthcare company. Its current price is $26.66 and its market capitalization is $92.66M. It ranks 4271 by market cap.
A major floor 32.5% below — a decisive break under it would weaken the trend.
The nearest floor, 14.9% below — buyers have tended to step in here.
Price is pressing into resistance (2.7% away) — a breakout level to watch.
A major ceiling 13.5% above — clearing it would confirm fresh momentum.
Key PTHS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PTHS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $27.00 | Sell | $26.95 | Buy |
| MA 10 | $26.86 | Buy | $26.74 | Buy |
| MA 20 | $26.18 | Buy | $26.11 | Buy |
| MA 50 | $24.11 | Buy | $24.97 | Buy |
| MA 100 | $24.06 | Buy | $24.68 | Buy |
| MA 200 | $26.16 | Buy | $23.97 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.03 | Neutral |
| Stoch RSI (14) | 12.91 | Buy |
| CCI (20) | 59.79 | Neutral |
| Williams %R (14) | -27.44 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 5.75 | Buy |
| Bollinger %B (20,2) | 0.71 | Neutral |
| Stochastic %K (14) | 72.56 | Neutral |
| TRIX (15) | 0.55 | Buy |
| Awesome (5,34) | 2.04 | Buy |
| Ultimate (7,14,28) | 57.95 | Neutral |
| Momentum (10) | -0.28 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 27.03 | Sell |
| ADX (14) | 20.50 | Buy |
| ATR (14) | 0.53 | Info |
The 30-day technical picture is bullish overall. RSI14 is 60, with the stock hovering around the SMA50 of $23.99 and the SMA200 of $26.08.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.19 | $26.96 | $33.69 | 0% | Neutral | |
| $22.22 | $28.46 | $38.82 | +6% | Neutral | |
| $22.60 | $29.89 | $42.44 | +11% | Neutral | |
| $25.58 | $34.75 | $50.95 | +29% | Bullish | |
| $29.72 | $41.35 | $62.27 | +53% | Bullish | |
| $33.39 | $47.49 | $73.22 | +76% | Bullish | |
| $37.65 | $54.67 | $86.07 | +103% | Bullish | |
| $35.31 | $52.27 | $83.89 | +94% | Bullish | |
| $34.85 | $52.56 | $85.83 | +95% | Bullish | |
| $38.77 | $59.53 | $98.81 | +121% | Bullish | |
| $57.52 | $95.81 | $170.21 | +255% | Bullish | |
| $84.42 | $162.38 | $318.30 | +502% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $18.19 | $26.96 | $31.69 | +0.00% |
| June 2026 | $22.52 | $26.54 | $32.09 | -1.56% |
| July 2026 | $22.68 | $26.99 | $33.14 | +1.69% |
| August 2026 | $23.06 | $27.66 | $34.37 | +2.49% |
| September 2026 | $22.23 | $26.83 | $33.66 | -3.01% |
| October 2026 | $21.26 | $25.81 | $32.67 | -3.77% |
| November 2026 | $21.43 | $26.15 | $33.35 | +1.30% |
| December 2026 | $21.39 | $26.23 | $33.69 | +0.29% |
Click any year to see its month-by-month PTHS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, PTHS is projected to trade between $18.19 and $33.69, averaging $26.96 — a potential gain of 0% from today's $26.96. Price action looks broadly range-bound.
Pelthos Therapeutics Inc.'s 2027 outlook centres on $28.46, within a $22.22 to $38.82 range. That is up +6% on the projected 2026 average. That marks a +6% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, PTHS could reach as high as $42.44, with a base case around $29.89 and support toward $22.60 — roughly +11% from $26.96. Price action looks broadly range-bound.
Expect PTHS to range from $25.58 to $50.95 through 2029. The $34.75 average target implies a +29% move from current prices. That is up +16% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The PTHS price prediction for 2030 points to an average of $41.35 (low $29.72, high $62.27) — a potential gain of +53% on today's $26.96. Momentum favours further upside here.
In 2031, PTHS is projected to trade between $33.39 and $73.22, averaging $47.49 — a potential gain of +76% from today's $26.96. That is up +15% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Pelthos Therapeutics Inc.'s 2032 outlook centres on $54.67, within a $37.65 to $86.07 range. That is up +15% on the projected 2031 average. That marks a +103% change versus current levels. Momentum favours further upside here.
By 2033, PTHS could reach as high as $83.89, with a base case around $52.27 and support toward $35.31 — roughly +94% from $26.96. Buyers look set to stay in control over this stretch.
Expect PTHS to range from $34.85 to $85.83 through 2034. The $52.56 average target implies a +95% move from current prices. That is up +1% on the projected 2033 average. Momentum favours further upside here.
The PTHS price prediction for 2035 points to an average of $59.53 (low $38.77, high $98.81) — a potential gain of +121% on today's $26.96. Buyers look set to stay in control over this stretch.
In 2040, PTHS is projected to trade between $57.52 and $170.21, averaging $95.81 — a potential gain of +255% from today's $26.96. That is up +61% on the projected 2035 average. Momentum favours further upside here.
Pelthos Therapeutics Inc.'s 2050 outlook centres on $162.38, within a $84.42 to $318.30 range. That is up +69% on the projected 2040 average. That marks a +502% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in PTHS today (≈ 37.091988 PTHS) could be worth
$6,022.87
+$5,022.87 (+502%) by 2050 · US Dollar
Based on the average projected PTHS price of $162.38 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PTHSwould be worth at today's price.
$1,000 invested in PTHS on May 27, 2025 (≈ 103.092786 PTHS) would be worth
$2,779.38
+$1,779.38 (+177.9%) today · 2.78× · US Dollar
Based on a PTHS entry price of $9.7 vs. today's $26.96.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.11 | $994.47 | -0.6% |
| 1 month ago | $24.77 | $1,088.41 | +8.8% |
| 3 months ago | $23 | $1,172.17 | +17.2% |
| 6 months ago | $28.4 | $949.3 | -5.1% |
| 1 year ago | $9.7 | $2,779.38 | +177.9% |
| All time (2.3y) ago | $48 | $561.67 | -43.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PTHS forecast.
Our base-case forecast reaches $54.00 around 2032.
Implied market cap at $54.00: $187.68M
The multi-year forecast shows a rising average price (Avg) from 2026 onward, with 2026 Avg at $26.66 and 2030 Avg at $40.67, 2040 Avg at $94.00, and 2050 Avg at $157.32. The forecast also shows Max values of $61.31 (2030), $167.16 (2040), and $308.73 (2050), with ROI figures of 52.6%, 252.6%, and 490.1% respectively, and a bullish sentiment in 2030, 2040, and 2050.
Tap a question to reveal the answer.
2030 Avg $40.67, Min $29.21, Max $61.31; ROI 52.6%; Sentiment BULLISH.
Forecast shows growing average prices and ROIs across years, with 2026 Avg $26.66 (ROI 0%), 2030 Avg $40.67 (ROI 52.6%), 2040 Avg $94.00 (ROI 252.6%), and 2050 Avg $157.32 (ROI 490.1%), and a generally bullish outlook in later years.
Yes. The forecast maximums include $167.16 in 2040, which surpasses $100.
Current price is $26.66 and market cap is $92.66M.
30-day range is low $21.63 and high $32.86.
Pelthos Therapeutics Inc. Community Discussion
0Share your Pelthos Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.